Obesity Clinical Trial
Official title:
A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support
NCT number | NCT01664026 |
Other study ID # | PWeb123 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2012 |
Est. completion date | December 2013 |
Verified date | January 2019 |
Source | Clínica Bazterrica |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the effect of a 6-month web-based lifestyle modification program with and without
telephone counseling versus usual care in obese patients with cardiovascular risk factors on:
- Weight Loss
- Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol,
HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.
- Physical activity and eating habits
- Quality of life
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2013 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Male or female 25-70 years of age 2. Obese (BMI = 30 kg/m2 and <40 kg/m2) 3. At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C =130 mg/dL and/or HDL-C <40 mg/dL and triglycerides =150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose =126 mg/dL in two consecutive office visits 4. Participant must be willing and able to provide written informed consent 5. Participant must be willing and able to comply with study related procedures 6. Participant must have access to Internet and e-mail Exclusion Criteria: 1. Stage 1 or 2 on Patient Activation Measures tool 2. Weight change of more than 5 kg during the 3 months preceding the screening visit 3. History of bariatric surgery 4. Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L) 5. Hemoglobin A1c at screening >8.5% 6. Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months) 7. Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure >160/100 mmHg 8. Secondary hypertension 9. Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit 10. Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke 11. Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult. 12. Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study 13. Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer 14. Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening 15. Use of any investigational agent (drug, biologic, device) within 3 months prior to screening |
Country | Name | City | State |
---|---|---|---|
Argentina | Clinica Bazterrica | Buenos Aires |
Lead Sponsor | Collaborator |
---|---|
Clínica Bazterrica |
Argentina,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Changes in lifestyle behaviors (physical activity and eating habits) | 6 months | ||
Other | Changes in quality of life | 6 months | ||
Primary | Change in body weight from randomization to 6 months | 6 months | ||
Secondary | Changes in waist circumference | 6 months | ||
Secondary | Changes in blood pressure | 6 months | ||
Secondary | Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol) | 6 months | ||
Secondary | Changes in glycemic parameters (glucose and hemoglobin A1c) | 6 months | ||
Secondary | Changes in C-reactive protein | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |